The future of the BayWa Group hangs in the balance, with its fate being determined not in the boardroom but at the negotiating tables of its creditor banks. A crucial element of its recovery strategy has collapsed, leaving a significant financial shortfall that the company is struggling to address.
Leadership and Governance in Flux
The ongoing crisis is triggering significant changes at the top. Chief Executive Officer Dr. Frank Hiller will depart the company on July 31, 2026. Furthermore, three supervisory board members, including Michael Höllerer and Monika Hohlmeier, are stepping down this spring. In a move reflecting tightened oversight, the supervisory board has also reduced the internal approval threshold for business transactions from 200 million euros to 50 million euros.
A Billion-Euro Gap Emerges
Central to the company’s survival is a standstill agreement with its core banking partners, such as DZ Bank and HVB. This agreement is intended to provide the conglomerate with financial breathing room until autumn 2026. Without it, management lacks the operational foundation to proceed. A debt haircut and subordination by creditors are now considered highly probable.
The failure of the planned sale of its renewable energy subsidiary, BayWa r.e., has blown a major hole in the restructuring blueprint. That divestment was projected to contribute 1.7 billion euros by 2028, but deteriorated regulatory conditions for project developers in the United States scuttled the deal. To date, BayWa has secured only 1.3 billion euros of its targeted 4 billion euro restructuring volume.
Should investors sell immediately? Or is it worth buying BayWa?
Operational Contraction and Delayed Reporting
The group’s operational planning underscores the severity of its situation. Management has withdrawn its financial forecast for 2026 and has lowered its adjusted EBITDA target for 2027 to approximately 140 million euros. The strategic plan now involves a sharp contraction: by the end of 2028, BayWa aims to be concentrated on four core business areas, with revenue reduced to about 10 billion euros and roughly 1,300 positions eliminated.
A pending payment of 45 million euros from the earlier sale of Cefetra is due at the end of April. Combined with the deconsolidation of certain assets, these measures are expected to reduce group bank debt by over 600 million euros. While this represents progress, it only marginally narrows the overall funding gap.
For investors, an additional complication arises from significant reporting delays. Due to the complex structural measures underway, the audited group financial statements for 2025 will not be released until the fourth quarter of 2026. A reliable data basis for a comprehensive revaluation of the company will only be available at that point—and only if the critical bank negotiations this autumn result in a successful agreement.
Ad
BayWa Stock: Buy or Sell?! New BayWa Analysis from April 7 delivers the answer:
The latest BayWa figures speak for themselves: Urgent action needed for BayWa investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 7.
BayWa: Buy or sell? Read more here...









